Authors’ Reply to Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”

被引：0

作者：

Edward E. Neuberger

Josh J. Carlson

David L. Veenstra

机构：

[1] Genentech,The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, Department of Pharmacy

[2] Inc.,undefined

[3] University of Washington,undefined

来源：

PharmacoEconomics | 2021年 / 39卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：477 / 478

页数：1

共 50 条

[1] Authors' Reply to Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome"
Neuberger, Edward E.
Carlson, Josh J.
Veenstra, David L.
PHARMACOECONOMICS, 2021, 39 (04) : 477 - 478
[2] Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome"
Hollenack, Kelly
Marshall, Jade
PHARMACOECONOMICS, 2021, 39 (04) : 473 - 475
[3] Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
Kelly Hollenack
Jade Marshall
PharmacoEconomics, 2021, 39 : 473 - 475
[4] Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
Edward E. Neuberger
Josh J. Carlson
David L. Veenstra
PharmacoEconomics, 2020, 38 : 1237 - 1245
[5] Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
Neuberger, Edward E.
Carlson, Josh J.
Veenstra, David L.
PHARMACOECONOMICS, 2020, 38 (11) : 1237 - 1245
[6] COST-EFFECTIVENESS OF CANNABIDIOL (CBD) FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH TREATMENT-RESISTANT LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME IN THE NETHERLANDS
Siddiqui, J.
Bowditch, S.
VALUE IN HEALTH, 2023, 26 (12) : S127 - S128
[7] Cannabidiol for Treatment of Patients With Seizures Associated With Lennox-Gastaut Syndrome
不详
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (04) : 546 - 546
[8] Cost-effectiveness analysis of antiepileptic drugs in the treatment of Lennox-Gastaut syndrome
Clements, Karen M.
Skornicki, Michelle
O'Sullivan, Amy K.
EPILEPSY & BEHAVIOR, 2013, 29 (01) : 184 - 189
[9] COST-EFFECTIVENESS ANALYSIS OF ANTIEPILEPTIC DRUGS IN THE TREATMENT OF LENNOX-GASTAUT SYNDROME
Clements, K. M.
Skornicki, M.
O'Sullivan, A. K.
VALUE IN HEALTH, 2012, 15 (04) : A144 - A144
[10] Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome
Lattanzi, S.
Trinka, E.
Russo, E.
Striano, P.
Citraro, R.
Silvestrini, M.
Brigo, F.
DRUGS OF TODAY, 2019, 55 (03) : 177 - 196

← 1 2 3 4 5 →